Cover Image
市場調查報告書

ISA Pharmaceuticals B.V. :產品平台分析

ISA Pharmaceuticals B.V. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 226263
出版日期 內容資訊 英文 26 Pages
訂單完成後即時交付
價格
Back to Top
ISA Pharmaceuticals B.V. :產品平台分析 ISA Pharmaceuticals B.V. - Product Pipeline Review - 2015
出版日期: 2015年08月31日 內容資訊: 英文 26 Pages
簡介

ISA Pharmaceuticals B.V. 是致力開發經由合理設計,完全合成的癌症及持續性病毒感染疾病治療藥的生物製藥公司。該公司的產品尚用於子宮頸癌和卵巢癌,直腸癌,其他感染疾病的治療上。

本報告提供ISA Pharmaceuticals B.V. 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

ISA Pharmaceuticals B.V.的基本資料

  • ISA Pharmaceuticals B.V.概要
  • 主要資訊
  • 企業資料

ISA Pharmaceuticals B.V.:R&D概要

  • 主要的治療範圍

ISA Pharmaceuticals B.V.:評估

  • 各開發階段的開發中產品
  • 單劑產品

ISA Pharmaceuticals B.V.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

ISA Pharmaceuticals B.V.:藥物簡介

  • ISA-101
  • ISA-102
  • ISA-203
  • SLP-AMPLIVANT-Conjugates

ISA Pharmaceuticals B.V.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型

ISA Pharmaceuticals B.V.:最近的開發平台趨勢

ISA Pharmaceuticals B.V.:暫停中的計劃

ISA Pharmaceuticals B.V.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07382CDB

Summary

Global Markets Direct's, 'ISA Pharmaceuticals B.V. - Product Pipeline Review - 2015', provides an overview of the ISA Pharmaceuticals B.V.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of ISA Pharmaceuticals B.V.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of ISA Pharmaceuticals B.V. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of ISA Pharmaceuticals B.V.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the ISA Pharmaceuticals B.V.'s pipeline products

Reasons to buy

  • Evaluate ISA Pharmaceuticals B.V.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of ISA Pharmaceuticals B.V. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the ISA Pharmaceuticals B.V.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of ISA Pharmaceuticals B.V. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of ISA Pharmaceuticals B.V.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of ISA Pharmaceuticals B.V. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • ISA Pharmaceuticals B.V. Snapshot
    • ISA Pharmaceuticals B.V. Overview
    • Key Information
    • Key Facts
  • ISA Pharmaceuticals B.V. - Research and Development Overview
    • Key Therapeutic Areas
  • ISA Pharmaceuticals B.V. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • ISA Pharmaceuticals B.V. - Pipeline Products Glance
    • ISA Pharmaceuticals B.V. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • ISA Pharmaceuticals B.V. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • ISA Pharmaceuticals B.V. - Drug Profiles
    • ISA-101
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ISA-201
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ISA-203
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ISA-204
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Vaccines for Oncology and Infectious Diseases
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • ISA Pharmaceuticals B.V. - Pipeline Analysis
    • ISA Pharmaceuticals B.V. - Pipeline Products by Target
    • ISA Pharmaceuticals B.V. - Pipeline Products by Route of Administration
    • ISA Pharmaceuticals B.V. - Pipeline Products by Molecule Type
  • ISA Pharmaceuticals B.V. - Recent Pipeline Updates
  • ISA Pharmaceuticals B.V. - Dormant Projects
  • ISA Pharmaceuticals B.V. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • ISA Pharmaceuticals B.V., Key Information
  • ISA Pharmaceuticals B.V., Key Facts
  • ISA Pharmaceuticals B.V. - Pipeline by Indication, 2015
  • ISA Pharmaceuticals B.V. - Pipeline by Stage of Development, 2015
  • ISA Pharmaceuticals B.V. - Monotherapy Products in Pipeline, 2015
  • ISA Pharmaceuticals B.V. - Phase II, 2015
  • ISA Pharmaceuticals B.V. - Phase I, 2015
  • ISA Pharmaceuticals B.V. - Preclinical, 2015
  • ISA Pharmaceuticals B.V. - Pipeline by Target, 2015
  • ISA Pharmaceuticals B.V. - Pipeline by Route of Administration, 2015
  • ISA Pharmaceuticals B.V. - Pipeline by Molecule Type, 2015
  • ISA Pharmaceuticals B.V. - Recent Pipeline Updates, 2015
  • ISA Pharmaceuticals B.V. - Dormant Developmental Projects,2015
  • ISA Pharmaceuticals B.V., Subsidiaries

List of Figures

  • ISA Pharmaceuticals B.V. - Pipeline by Top 10 Indication, 2015
  • ISA Pharmaceuticals B.V. - Pipeline by Stage of Development, 2015
  • ISA Pharmaceuticals B.V. - Monotherapy Products in Pipeline, 2015
  • ISA Pharmaceuticals B.V. - Pipeline by Top 10 Route of Administration, 2015
  • ISA Pharmaceuticals B.V. - Pipeline by Top 10 Molecule Type, 2015
Back to Top